{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T09:41:56Z","timestamp":1762249316353,"version":"3.37.3"},"reference-count":7,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,12,1]],"date-time":"2010-12-01T00:00:00Z","timestamp":1291161600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["dmd.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Disposition"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1124\/dmd.110.033670","type":"journal-article","created":{"date-parts":[[2010,8,26]],"date-time":"2010-08-26T02:25:24Z","timestamp":1282789524000},"page":"2266-2277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Metabolism of Vabicaserin in Mice, Rats, Dogs, Monkeys, and Humans"],"prefix":"10.1016","volume":"38","author":[{"given":"Zeen","family":"Tong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Appavu","family":"Chandrasekaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"DeMaio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Espina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JoAnn","family":"Scatina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/dmd.110.033670_bib1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/(SICI)1098-2396(200001)35:1<53::AID-SYN7>3.0.CO;2-2","article-title":"Preferential modulation of mesolimbic vs. nigrostriatal dopaminergic function by serotonin(2C\/2B) receptor agonists: a combined in vivo electrophysiological and microdialysis study","volume":"35","author":"Di Giovanni","year":"2000","journal-title":"Synapse"},{"key":"10.1124\/dmd.110.033670_bib2","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/S0028-3908(99)00047-7","article-title":"SB 242084, a selective serotonin2C receptor antagonist, increases dopaminergic transmission in the mesolimbic system","volume":"38","author":"Di Matteo","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1124\/dmd.110.033670_bib3","series-title":"36th Annual Meeting for the Society for Neuroscience; 2006 Oct 14\u201318; Atlanta, GA","article-title":"In vitro pharmacological profile of SCA-136, a novel 5-HT2C receptor selective agonist","author":"Dunlop","year":"2006"},{"key":"10.1124\/dmd.110.033670_bib4","series-title":"36th Annual Meeting for the Society for Neuroscience; 2006 Oct 14\u201318; Atlanta, GA","article-title":"SCA-136: a novel 5-HT2C receptor agonist possessing atypical antipsychotic-like effects in preclinical models","author":"Marquis","year":"2006"},{"key":"10.1124\/dmd.110.033670_bib5","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0028-3908(98)00078-1","article-title":"Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo","volume":"37","author":"Millan","year":"1998","journal-title":"Neuropharmacology"},{"key":"10.1124\/dmd.110.033670_bib6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.3109\/03602539208996289","article-title":"Acyl glucuronides revisited: is the glucuronidation process a toxification as well as a detoxification mechanism?","volume":"24","author":"Spahn-Langguth","year":"1992","journal-title":"Drug Metab Rev"},{"key":"10.1124\/dmd.110.033670_bib7","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1124\/dmd.109.028639","article-title":"Species differences in the formation of vabicaserin carbamoyl glucuronide","volume":"38","author":"Tong","year":"2010","journal-title":"Drug Metab Dispos"}],"container-title":["Drug Metabolism and Disposition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624025728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090955624025728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/dmd.110.033670","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T16:48:32Z","timestamp":1739897312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090955624025728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,12]]},"references-count":7,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["S0090955624025728"],"URL":"https:\/\/doi.org\/10.1124\/dmd.110.033670","relation":{},"ISSN":["0090-9556"],"issn-type":[{"type":"print","value":"0090-9556"}],"subject":[],"published":{"date-parts":[[2010,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolism of Vabicaserin in Mice, Rats, Dogs, Monkeys, and Humans","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Disposition","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/dmd.110.033670","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2011 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}